NCNA
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
32.78M
NRXP
Price
$3.42
Change
-$0.08 (-2.29%)
Updated
Jun 27 closing price
Capitalization
66.7M
Interact to see
Advertisement

NCNA vs NRXP

Header iconNCNA vs NRXP Comparison
Open Charts NCNA vs NRXPBanner chart's image
NuCana
Price$0.08
Change-$0.00 (-0.00%)
Volume$10.62M
Capitalization32.78M
NRX Pharmaceuticals
Price$3.42
Change-$0.08 (-2.29%)
Volume$259.89K
Capitalization66.7M
NCNA vs NRXP Comparison Chart in %
Loading...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NCNA vs. NRXP commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCNA is a Hold and NRXP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (NCNA: $0.08 vs. NRXP: $3.42)
Brand notoriety: NCNA and NRXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NCNA: 9% vs. NRXP: 85%
Market capitalization -- NCNA: $32.78M vs. NRXP: $66.7M
NCNA [@Biotechnology] is valued at $32.78M. NRXP’s [@Biotechnology] market capitalization is $66.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NCNA’s FA Score shows that 0 FA rating(s) are green whileNRXP’s FA Score has 0 green FA rating(s).

  • NCNA’s FA Score: 0 green, 5 red.
  • NRXP’s FA Score: 0 green, 5 red.
According to our system of comparison, NRXP is a better buy in the long-term than NCNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NCNA’s TA Score shows that 4 TA indicator(s) are bullish while NRXP’s TA Score has 2 bullish TA indicator(s).

  • NCNA’s TA Score: 4 bullish, 3 bearish.
  • NRXP’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, NCNA is a better buy in the short-term than NRXP.

Price Growth

NCNA (@Biotechnology) experienced а -17.40% price change this week, while NRXP (@Biotechnology) price change was +4.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXP($66.7M) has a higher market cap than NCNA($32.8M). NRXP YTD gains are higher at: 55.455 vs. NCNA (-93.059). NCNA has higher annual earnings (EBITDA): -16.98M vs. NRXP (-24.11M). NRXP has more cash in the bank: 5.55M vs. NCNA (3.95M). NCNA has less debt than NRXP: NCNA (173K) vs NRXP (8.4M). NCNA (0) and NRXP (0) have equivalent revenues.
NCNANRXPNCNA / NRXP
Capitalization32.8M66.7M49%
EBITDA-16.98M-24.11M70%
Gain YTD-93.05955.455-168%
P/E RatioN/A0.36-
Revenue00-
Total Cash3.95M5.55M71%
Total Debt173K8.4M2%
FUNDAMENTALS RATINGS
NCNA vs NRXP: Fundamental Ratings
NCNA
NRXP
OUTLOOK RATING
1..100
9127
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5235
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NCNA's Valuation (52) in the Biotechnology industry is in the same range as NRXP (57) in the null industry. This means that NCNA’s stock grew similarly to NRXP’s over the last 12 months.

NCNA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NRXP (100) in the null industry. This means that NCNA’s stock grew similarly to NRXP’s over the last 12 months.

NCNA's SMR Rating (99) in the Biotechnology industry is in the same range as NRXP (100) in the null industry. This means that NCNA’s stock grew similarly to NRXP’s over the last 12 months.

NRXP's Price Growth Rating (35) in the null industry is in the same range as NCNA (52) in the Biotechnology industry. This means that NRXP’s stock grew similarly to NCNA’s over the last 12 months.

NRXP's P/E Growth Rating (94) in the null industry is in the same range as NCNA (100) in the Biotechnology industry. This means that NRXP’s stock grew similarly to NCNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NCNANRXP
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
70%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 19 days ago
79%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBTTF0.04N/A
+0.42%
Cathedra Bitcoin Inc
SCGPY2.78N/A
N/A
Serco Group Plc.
WFCNP1.50N/A
N/A
Wells Fargo & Co.
DRETF10.97N/A
N/A
Dream Office Real Estate Investment Trust
CMSQY25.88-0.06
-0.23%
Computershare Ltd.

NCNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with CDTX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
N/A
CDTX - NCNA
93%
Closely correlated
+0.24%
NBY - NCNA
92%
Closely correlated
+0.97%
WINT - NCNA
92%
Closely correlated
+21.49%
RNAC - NCNA
92%
Closely correlated
-6.81%
SNPX - NCNA
92%
Closely correlated
+23.37%
More

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with CDTX. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
-2.29%
CDTX - NRXP
85%
Closely correlated
+0.24%
NBY - NRXP
84%
Closely correlated
+0.97%
NCNA - NRXP
84%
Closely correlated
N/A
RNAC - NRXP
83%
Closely correlated
-6.81%
ALLR - NRXP
83%
Closely correlated
+2.12%
More